Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Radiology|March 4, 2020
Pediatric Chest Radiographic and CT Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI)Maddy Artunduaga, Devika Rao, Jonathan Friedman, et al.
International Journal of Medical Informatics|October 8, 2022
Effects of the electronic health record on job satisfaction of academic pediatric facultyAbigail M Kissel, Katherine Maddox, Jenny K R Francis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal CancerJeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, et al.
Cancer Medicine|June 6, 2022
Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomesLilly Gu, Paras P Mehta, Devika Rao, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 21, 2011
The school inner-city asthma study: design, methods, and lessons learnedWanda Phipatanakul, Anne Bailey, Elaine B Hoffman, et al.
Cardiovascular and Interventional Radiology|September 9, 2025
Tumor Absorbed Dose Predicts Survival and Local Tumor Control in Colorectal Liver Metastases Treated with 90Y RadioembolizationMarios-Platon Dimopoulos, Vlasios S Sotirchos, Cynthia Dunne-Jaffe, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Nature Communications|February 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinomaPaul B Romesser, Aron Bercz, Janet Alvarez, et al.
Research Square|September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II TrialWungki Park, Catherine O'Connor, Joanne Chou, et al.
Pageof 3